Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience

To investigate whether the use of IL-6 receptor antagonist (tocilizumab) might be associated with hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients, particularly in those with resolved HBV infection [HBV surface antigen (HBsAg) negative and antibody to HBV core antigen (anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Soo, Jung, Seung Min, Song, Jason Jungsik, Park, Yong-Beom, Park, Jun Yong, Lee, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889999/
https://www.ncbi.nlm.nih.gov/pubmed/29611409
http://dx.doi.org/10.3349/ymj.2018.59.3.452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889999/
https://www.ncbi.nlm.nih.gov/pubmed/29611409
http://dx.doi.org/10.3349/ymj.2018.59.3.452

Ejemplares similares